Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 231-927-0 | CAS number: 7779-31-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Link to relevant study record(s)
Description of key information
No experimental toxicokinetic study is available on 3.3.5-trimethylcyclohexyl methacrylate.
However, as per REACH guidance document R7.C , information on absorption, distribution, metabolism and excretion may be deduced from the physical-chemical properties and QSAR predictions.
Based on the physical-chemical properties and QSAR predictions, the absorption of 3.3.5-trimethylcyclohexyl methacrylate is expected to be high by oral route and inhalation, but low by dermal route.. A good distribution and excretion of the substance are expected.
Key value for chemical safety assessment
- Bioaccumulation potential:
- no bioaccumulation potential
- Absorption rate - oral (%):
- 100
- Absorption rate - dermal (%):
- 10
- Absorption rate - inhalation (%):
- 100
Additional information
No experimental toxicokinetic study is available on 3.3.5 -trimethylcyclohexyl methacrylate.
However, as per REACH guidance document R7.C, information on absorption, distribution, metabolism and excretion may be deduced from the physical-chemical properties, including:
-Mean molecular weight: 210.32 g/mol
-Water solubility: 5.3 mg/L (20°C)
-Partition coefficient Log Kow: 5.25
-Vapour pressure: 7.3 Pa (25°C)
ABSORPTION
The high value of log Kow (>4) and the low solubility (<100 mg/L) of 3.3.5 -trimethylcyclohexyl methacrylate are favorable for a low oral absorption. No mortality or adverse effect were observed after one single administration (5000 mg/kg) of 3.3.5-trimethylcyclohexyl methacrylate by gavage (oral route) in rat.
However using a model to predict either high or low fraction absorbed for an orally administered, passively transported substance, the rates of absorption of 3,3,5-trimethylcyclohexyl methacrylate were 100 and 90% for a dose of 1 and 1000 mg, respectively (Danish QSAR). According to the model "Intestinal absorption (human)", 96.159% of the substance is absorbed (pkCSM). That's why 100% of oral absorption is taken into account for the risk assessment.
With a solubility of 5.3 mg/L, dermal absorption is anticipated to be low. A Log Kow higher than 4 suggests that the rate of penetration of the substance may be limited by the rate of transfer between the stratum corneum and the epidermis. However, a molecular mass smaller than 500 g/mol are favourable to a dermal absorption. The methacrylates are known to bind to skin components, and this binding decreases their dermal absorption. According to the IH skin perm (QSAR), the dermal absorption of 3,3,5-trimethylcyclohexyl methacrylate is 0.55%.That's why 10% of absorption is taken into account for the risk assessment.
3.3.5-trimethylcyclohexyl methacrylate showed allergic reaction in the LLNA: it is evidence that some uptake must have occurred although it may only have been a small fraction of the applied dose. That's why 10% of dermal absorption is taken into account for the risk assessment.
Based on the vapour pressure (7.3 Pa), 3.3.5 -trimethylcyclohexyl methacrylate is considered to be not a volatile substance because lower than 100 Pa. Indeed, the absorption by inhalation can be expected to be low for 3.3.5-trimethylcyclohexyl methacrylate based on the values of low water solubility and high log kow. However 100% of absorption is taken into account for the risk assessment (worst case).
DISTRIBUTION
No specific data is available on the distribution of 3.3.5-trimethylcyclohexyl methacrylate.
No specific organ toxicity was showed in the repeated studies in the analogue substance : 3.3.5 -trimethylcyclohexyl acrylate.
According to the QSAR pkCSM, the substance is well distributed into the body including in the CNS.
METABOLISM
There are no experimental study on metabolism of 3.3.5 -trimethylcyclohexyl methacrylate.
In silico tool (OECD QSAR Toolbox) was used to predict metabolites. OECD Toolbox contains simulators of liver metabolism and hydrolysis in acidic condition. Acidic hydrolysis is expected and two metabolites are identified : 3,3,5-trimethylcyclohexanol and methacrylic acid.
The Rat liver S9 metabolism simulator showed 7 metabolites including 3,3,5-trimethylcyclohexanol and methacrylic acid.
ELIMINATION
Due to the low water solubility, the excretion of 3.3.5 -trimethylcyclohexyl methacrylate in the urines is expected to be low. An excretion via bile and faeces is possible. According to the QSAR pkCSM, a moderate/high total clearance (hepatic & renal) is expected.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.